Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | ELV | GILD |
|---|
| Close | 412.56 | 147.68 |
| Market Cap | $89.5B | $183B |
| 1M | +5.72% | +6.31% |
| P/E (TTM) | 18.2 | — |
| Forward P/E | 13.2 | 25.3 |
| P/E 5-Yr Percentile | 71 | — |
| P/S | 0.5 | 6.0 |
| P/B | 2.0 | 15.3 |
| Dividend Yield | 1.24% | 3.98% |
| Latest Quarter Revenue | $50.5B | $7.8B |
| Revenue YoY | +1.4% | +10.2% |
| Gross Margin | 89.1% | 79.8% |
| Latest Quarter EPS | 6.71 | -8.45 |
| Avg Post-Earnings Move | ±4.0% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.70% | 3.01% |
| 90-Day Net Insider Buying | +$1.4M | −$15.4M |
ELV · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
